Screening fructosamine-3-kinase (FN3K) inhibitors, a deglycating enzyme of oncogenic Nrf2: Human FN3K homology modelling, docking and molecular dynamics simulations
Main Authors: | Narasimha M. Beeraka, Jin Zhang, Subhankar Mandal, Hemanth Vikram P. R., Junqi Liu, Namitha B. M., Di Zhao, Prashanth Vishwanath, Gurupadayya B. M., Ruitai Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619859/?tool=EBI |
Similar Items
-
Screening fructosamine-3-kinase (FN3K) inhibitors, a deglycating enzyme of oncogenic Nrf2: Human FN3K homology modelling, docking and molecular dynamics simulations.
by: Narasimha M Beeraka, et al.
Published: (2023-01-01) -
The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers
by: Narasimha M. Beeraka, et al.
Published: (2021-01-01) -
Enzymatic Deglycation of Damaged Skin by Means of Combined Treatment of Fructosamine-3-Kinase and Fructosyl-Amino Acid Oxidase
by: Ignace De Decker, et al.
Published: (2023-05-01) -
Structure of unliganded membrane-proximal domains FN4-FN5-FN6 of DCC
by: Lorenzo I. Finci, et al.
Published: (2017-06-01) -
Implications for collagen binding from the crystallographic structure of fibronectin 6FnI1-2FnII7FnI.
by: Erat, M, et al.
Published: (2010)